- Bloomberg•16 hours ago
China National Chemical Corp. said it filed for U.S. antitrust approval with the Federal Trade Commission for its proposed $43 billion takeover of Swiss agrochemical company Syngenta AG.
- Bloomberg•7 days ago
Investors are still too negative on Syngenta AG’s deal with China National Chemical Corp.
- Bloomberg Video•3 days ago
Jan.17 -- Michel Demare, chairman at Syngenta, talks about the prospect of regulatory approval of its deal with ChemChina, how the company's business model fits in with U.S. President-elect Donald Trump, and concerns over a U.S.-China trade war. He speaks with Bloomberg's Erik Schatzker from the World Economic Forum in Davos, Switzerland on "Bloomberg Markets."
SYNN.VX: Summary for SYNGENTA N - Yahoo Finance
SYNGENTA N (SYNN.VX)
Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
|Bid||430.00 x 60900|
|Ask||434.50 x 14500|
|Day's range||424.60 - 434.40|
|52-week range||351.80 - 434.40|
|PE ratio (TTM)||N/A|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|